Purpose Ventilation/perfusion tomography (V/P SPECT ), with new interpretation criteria and newer tracers for ventilation imaging, has markedly improved the diagnostic yield in acute pulmonary embolism (PE). Here, we evaluated the diagnostic performance of perfusion SPECT (P SPECT ) without ventilation imaging. Methods We studied 152 patients with clinically suspected PE who had been examined with both V/P SPECT and multidetector computed tomographic angiography (MD-CTA). The diagnosis or exclusion of PE was decided by the referring clinician based on both the V/P SPECT and/or MD-CTA findings in combination with the clinical findings. P SPECT images were retrospectively examined by a physician with experience in the interpretation of planar perfusion scans who was blinded to clinical, V/P SPECT and MD-CTA data. P SPECT images were interpreted without the aid of chest radiography. All the patients who were deemed to have PE were given anticoagulant therapy. Results Of the 152 patients, 59 (39 %) received a final diagnosis of PE, and 19 (32 %) had associated cardiopulmonary diseases such as pneumonia, COPD, or left heart failure. P SPECT correctly identified 53 (90 %) of the 59 patients with PE. The specificity was 88 of 93 (95 %). None of the P SPECT images was rated nondiagnostic. P SPECT yielded an overall diagnostic accuracy of 93 % (95 % confidence interval, CI, 87-96 %). At the observed PE prevalence of 39 %, the positive and negative predictive values of P SPECT were 91 % (95 % CI, 80-97 %) and 94 % (95 % CI, 86-97 %), respectively. Conclusion In managing critically ill patients, P SPECT might be a valid alternative to V/P SPECT or MD-CTA since it was able to identify most patients with PE with a low falsepositive rate and no inconclusive results.
Introduction
Pulmonary embolism (PE) is a common but still underdiagnosed condition. In a survey of the relevant literature from 1945 through 2002, PE was unsuspected or undiagnosed ante-mortem in 84 % of patients who had PE discovered at autopsy [1] . Remarkably, 78 % of patients with large or fatal PE were never suspected of having the disease during life [1] . Raising the suspicion of PE is the fundamental step in the diagnostic work-up because it allows selection of patients in whom objective tests are mandatory to confirm or exclude the diagnosis [2, 3] . Multidetector computed tomographic angiography (MD-CTA) is used by many as the first-line imaging technique for suspected PE. Contrast-enhanced CT has changed the practice of medicine, particularly in emergency departments [4] , but it has a number of contraindications, and is associated with a substantial radiation burden to the patient [5] .
Ventilation/perfusion (V/P) scintigraphy has long been used in the evaluation of suspected PE. In the first Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED I) study, only a minority of patients with established PE had a high probability on the V/P scan (segmental or lobar perfusion defect with normal ventilation). In most patients, V/P yielded inconclusive results [6] . In recent years, the advent of single photon emission CT (SPECT), new interpretation criteria, and the use of newer tracers for ventilation imaging have markedly improved the diagnostic accuracy of V/P scintigraphy in the diagnosis of acute PE. In a recent, broad investigation, a sensitivity of 99 %, and a specificity of 98 % were found [7] . In a prospective study published in 1996, planar perfusion scintigraphy (without ventilation imaging) yielded a sensitivity of 86 % and a specificity of 93 % in comparison with pulmonary angiography as the reference diagnostic standard [8] . Similar results were obtained from a retrospective examination of the planar perfusion scans from the PIOPED II study [9] .
In the present study, we evaluated the diagnostic performance of P SPECT in a sample of 152 patients suspected of having PE.
If P SPECT alone had a sensitivity and specificity similar to that of V/P SPECT , it could be a valuable alternative in managing critically ill patients and those who might not be able to cooperate due to multiple trauma or neurological disorders.
Patients and methods

Sample
Over a 1.5-year period, 152 patients with clinically suspected PE were examined with both V/P SPECT and MD-CTA at Skåne University Hospital, Lund, Sweden. The clinical suspicion of PE was based on the presence of relevant symptoms (unexplained dyspnoea, chest pain, fainting or syncope, haemoptysis, palpitations), and the presence of arterial hypoxaemia and/or signs of right ventricular strain on electrocardiography or echocardiography. No formal assessment of the pretest (clinical) probability of PE was made by the attending physicians.
V/P SPECT V/P SPECT was performed with a large field-of-view dualhead gamma camera with low-energy all-purpose collimators and a 64×64 matrix used with 128 projections over 360°. While in the supine position, patients inhaled aerosolized Immediately afterwards, and without moving the patient, 120 MBq 99m Tc-MAA, (TechneScan LyoMAA; Mallinckrodt Medical) was given intravenously for the perfusion study. This was followed by perfusion tomography in which the acquisition of each projection took 5 s. The patient carefully maintained his/her supine position during the ventilation/perfusion acquisition. Immobilization lasting 20 min was usually well tolerated even by critically ill patients. Iterative reconstruction was performed using ordered-subsets expectation maximization with eight subsets and two iterations. Ventilation background was subtracted from the perfusion tomogram, and a normalized V/P image set (V/P quotient ) was calculated. The methodology is described in full elsewhere [7, [10] [11] [12] .
In accordance with the European guidelines:
1. No PE: normal perfusion scan or a maximum of one mismatch point (one subsegment). 2. PE: one segmental or two subsegmental mismatches, at least two points.
Disorders other than PE: perfusion and ventilation de-
fects showing match or reversed mismatch. The reader reports if the pattern observed is suggestive of other lung diseases such as pneumonia, left heart failure, chronic obstructive pulmonary disease (COPD) or lung cancer. For the sake of this study, these alternative diagnoses are categorized as 'No PE'. 4. Nondiagnostic for PE: complex V/P defects which make the judgement of mismatch impossible or nontypical V/P defects.
In the present study, the V/P SPECT scans were interpreted by one of ten doctors of the Department of Clinical Physiology, Lund, as part of their daily clinical activities. For practical purposes, the extent of PE, as assessed by V/P SPECT , was categorized as small (occlusion less than 20 % of the pulmonary vascular bed), moderate (21-50 %), or large (greater than 50 %) [13] . P SPECT diagnostic criteria 1. No PE: no perfusion defects. 2. PE: single or multiple wedge-shaped perfusion defects, according to the European Association of Nuclear Medicine Guideline criteria, first used in the Prospective Investigative Study on Acute Pulmonary Embolism Diagnosis (PISA-PED) study [8] . 3. Disorders other than PE: perfusion defects other than wedge-shaped [8] . They are categorized here as 'No PE'.
P SPECT images were examined retrospectively by one of the authors (M.M., of the University of Florence, Italy) with long experience in the interpretation of planar perfusion scans. The reviewer was blinded to clinical, V SPECT , and MD-CTA data. The P SPECT images were interpreted without the aid of chest radiography.
Multidetector CT angiography
Patients were examined with a 16-multidetector CT scanner during a deep-inspiration breath-hold for 10 s. Technical conditions were: 120 kVp, 190 mAs per slice, 16×1.5 mm collimator, 0.5 s rotation time, and 0.938 pitch. The images were acquired in the caudocranial direction in a 512 × 512 matrix. Contrast medium (70 ml; Omnipaque; General Electric) was administered intravenously at 4 ml/s. Angiographic criteria for the diagnosis of PE included the identification of an embolus obstructing a vessel, or the outline of an embolus within a vessel.
Final diagnosis
The final diagnosis (PE present or absent) was established by the physician responsible for the patient's care. It was based on the clinical findings in combination with the results of both V/P SPECT and MD-CTA, or compression ultrasonography showing deep vein thrombosis in the patients in whom V/P SPECT or MD-CTA yielded inconclusive results. All the patients who were deemed to have PE received anticoagulant therapy. Anticoagulation was withheld or withdrawn in those who were deemed not to have PE. All the patients were followed for up to 3 months. Outcome measures included hospital readmissions for any cause, recurrent episodes of PE, and death.
Statistical analysis
Sensitivity is defined as the proportion of tests categorized as positive for PE among the patients who were deemed to have PE by the final clinical judgement. Specificity is the proportion of tests categorized as negative for PE among the patients who were deemed not to have PE. Accuracy is the sum of true positive and true negative results divided by the total number of patients. Positive predictive value is the proportion of patients with PE among those who had a positive test. Negative predictive value is the proportion of patients without PE among those who had a negative test. According to the binomial distribution, 95 % confidence intervals (CI) were calculated with continuity correction. The agreement between P SPECT and V/P SPECT , or MD-CTA ratings was tested using the kappa statistic. The statistical analysis was performed with Stata, version 10 (StataCorp, College Station, TX).
Results
The 152 patients included had a median age of 61 years (interquartile range 40-73 years), 76 (44 %) were men, 97 (64 %) were outpatients at the time of study entry, and 27 (18 %) had active cancer. The diagnosis or exclusion of PE was based on the congruent results of MD-CTA and V/P SPECT in 88 patients (58 %), MD-CTA in 9 patients (6 %), V/P SPECT in 53 patients (35 %), and compression ultrasonography in 2 patients (1 %). A final diagnosis of PE was established in 59 (39 %) of the 152 patients, by both MD-CTA and V/P SPECT in 28 patients, by V/P SPECT in 29 patients, and by compression ultrasonography showing deep vein thrombosis in 2 patients with inconclusive MD-CTA or V/P SPECT results. Of the 59 patients with PE, 19 (32 %) had associated cardiopulmonary disorders (pneumonia in 10, left heart failure in 5 and COPD in 2). One patient had PE, lung cancer and COPD, and one PE and lung cancer. The diagnosis of PE was excluded in 93 patients, by both MD-CTA and V/P SPECT in 61 patients, by MD-CTA in 8 patients, and by V/P SPECT in 24 patients. Of these 93 patients, 13 had pneumonia, 10 acute left heart failure, 10 exacerbation of COPD, and 2 lung cancer.
None of the patients, who were deemed not to have PE, developed symptomatic episodes of PE during a 3-month follow-up. None of the patients with established PE had recurrent embolic events during follow-up, and none died from PE. As shown in Table 1 , P SPECT correctly identified 53 (90 %) of the 59 patients with PE. The specificity was 88 of 93 (95 %). None of the P SPECT images was rated nondiagnostic. P SPECT yielded an overall diagnostic accuracy of 93 % (95 % CI 87-96 %). At the observed PE prevalence of 39 %, the positive and negative predictive values for P SPECT were 91 % (95 % CI 80-97 %) and 94 % (95 % CI 86-97 %), respectively. Figure 1 shows characteristic P SPECT images in a patient with multiple perfusion defects caused by PE. Figure 2 shows a patient with pneumonia who was misinterpreted as having PE on P SPECT . Figure 3 shows images in a patient with perfusion defects that were interpreted as true-negative for PE. The agreement between P SPECT ratings and MD-CTA was excellent (observed agreement 98 %, kappa 0.95), and it was very good with V/P SPECT (observed agreement 91 %, kappa 0.83).
Discussion
PE remains a challenging diagnostic problem because clinicians still fail to raise suspicion of the disease promptly. In recent years, MD-CTA has become the imaging modality of choice for PE in most hospitals worldwide. Mamlouk et al. evaluated retrospectively the medical records of 2003 consecutive patients who underwent MD-CTA for possible PE over a 1.5-year period [14] . The overall prevalence of PE was only 9.8 % (197/2003), and in particular, the occurrence of a positive angiogram in the patients with no risk factors for PE was as low as 1 % (5/520) [14] . It seems, therefore, that MD-CTA is increasingly used as a screening method rather than as a means to confirm or exclude clinically suspected PE. This may contribute to inflating the costs of diagnostic procedures for PE, and to expose the patients to an undue amount of radiation. Radiation exposure is of concern, especially in women of child-bearing age. In fact, using a contemporary 64-detector CTA protocol for PE, the absorbed dose to the female breast is in the range 3.5-4.2 cGy [15] , which is 30 times greater than that absorbed during V/P scintigraphy (0.08 cGy) [10] . In addition, MD-CTA is contraindicated in patients with renal failure, severe heart failure and allergy to contrast agents, and during pregnancy [10, 11] . Alternative imaging modalities will therefore continue to be needed.
In the present study, using the EANM interpretation criteria, P SPECT was accurate in diagnosing or excluding PE with a sensitivity of 90 %, and specificity of 95 %. In a recent investigation, Gutte et al., interpreted P SPECT images in conjunction with low-dose CT using a hybrid gamma camera [11, 16] . They found a sensitivity of 93 % but a specificity of only 51 %. Such a low specificity is probably due to the different criteria used for interpreting perfusion defects. In a recent multicentre study using planar imaging and MD-CTA, the sensitivity and specificity for planar lung scintigraphy for the detection of PE were 86 % and 81 %, respectively, when PISA-PED interpretation criteria were applied [17] . Sostman et al. found a sensitivity of planar perfusion imaging of 81 % (slightly lower than found be He at al.), but the specificity was 97 % [9, 17] [18] . They studied 52 patients with moderate or high clinical probability, using MD- CTA as the reference diagnostic standard. Tc-DI-80B3 uptake in the lungs was assessed by thoracic SPECT at 2.5 h after intravenous administration of the labelled antibody. Of 52 the patients, 42 (81 %) had both evaluable MD-CTA and a 99m Tc-DI-80B3 scan. The latter yielded a sensitivity for PE of 76 % (95 % CI 53-92 %) and a specificity of 90.5 % (95 % CI, 70-99 %) [18] . The sensitivity is far lower than ours with P SPECT .
The high diagnostic accuracy of P SPECT is of importance because this technique could be advantageously used in clinical practice, especially in patients in whom ventilation imaging cannot be performed such as those who are clinically unstable or unconscious, or women during the first trimester of pregnancy. However, it should be born in mind that small emboli in the lingula and the right middle lobe might be missed by P SPECT due to the shape of these segments. Furthermore, falsepositive P SPECT may occur in some patients with pneumonia ( Fig. 2) or COPD.
Our study had some limitations. First, in 35 % of the patients, although MD-CTA results were available, the V/P SPECT report was used by the clinicians as referent to diagnose or exclude PE. In some of these patients this was dependent on inconclusive MD-CTA findings. However, it is unlikely that an incorporation bias occurred because the physician in charge of examining the P SPECT images was blinded to the reference diagnostic technique and all other clinical data. Second, the study sample was relatively small. Third, P SPECT images were interpreted by one reader only. Further studies are needed to assess interobserver agreement in interpreting P SPECT images, and to establish whether the examination of chest radiographs could improve the diagnostic performance of P SPECT [9] . Fourth, the diagnosis or exclusion of PE was based on the results of two imaging modalities (MD-CTA and V/P SPECT ) that feature different characteristics.
In the past, selective or superselective pulmonary angiography has been used as the reference diagnostic standard for PE [3, 6] . Conventional pulmonary angiography is now seldom used in clinical practice, its application being restricted to highly specialized centres. In the PIOPED II, a multicentre study aimed at assessing the accuracy of MD-CTA, a composite reference standard was used to diagnose or rule out PE [19] . This included the evaluation of one or more of the following tests: digital subtraction pulmonary angiography (DSA), V/P lung scintigraphy, and venous compression ultrasonography. DSA was performed in only 225 (27 %) of the 824 patients enrolled in the study.
In summary, the present results suggest that P SPECT might be a valid alternative to V/P SPECT in patients in whom ventilation imaging cannot be performed, since it allows identification of most patients with PE with a low falsepositive rate and no inconclusive results.
